Study Stopped
No patients recruited. Study didn't get off the ground. PI left.
Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The investigators hypothesize that the use of leptospermum scoparium honey as a type of dressing and/or debridement agent on stage III or IV pressure ulcers has an increased efficacy and safety compared to the current treatment protocol that includes the use of hydrogel/Vaseline, collagenase, and silver alginate dressings as the standard of care. Utilizing a non-inferiority trial, it is expected that the use of leptospermum scoparium as a treatment for Stage III and Stage IV pressure ulcers will not be inferior to the comparison treatment of standard of care wound dressings. Moreover, this research design will enable the research team to determine if the honey based dressings are equivalent to or superior to the comparison treatment. Therefore, the investigators specific study objectives are as follows:
- 1.Primary Objectives: Determine if the use of honey as an alternative treatment will reduce site inflammation/irritation and pain associated with pressure ulcers compared to the standard treatment options. Specifically, the investigators will monitor patient PUSH scores, Braden Risk Scale scores, granulation and/or epithelial tissue progression, length of time to heal, patient pain assessments via the Wong Baker Face or Numeric Scale, wound odors, and incidence of adverse events (measured by allergies, stinging sensations, bacterial infections that warrant antibiotic intervention, etc.).
- 2.Secondary Objective: Patients in the honey treatment group will have lower costs per healed ulcer than patients in the standard collagenase treatment group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2018
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2016
CompletedFirst Posted
Study publicly available on registry
February 23, 2016
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedApril 18, 2018
April 1, 2018
1 month
February 8, 2016
April 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Total Score on the Pressure Ulcer Scale for Healing (PUSH) Scale
Developed by the National Pressure Ulcer Advisory Panel (NPUAP) as a quick and reliable tool to monitor the change in pressure ulcer status over time and has been incorporated as a standard assessment tool in acute care settings.
6 weeks
Odor (scored as no odor, odor on dressing change, odor all the time)
Observed by staff and patient, will be scored as no odor, odor on dressing change, odor all the time.
6 weeks
Incidence of adverse events
6 weeks
Braden Scale assessment
6 weeks
Irritation
Presence or absence of irritation as determined by clinical observation
6 weeks
Inflammation
Presence or absence of irritation as determined by clinical observation
6 weeks
Pain
Pain in and around pressure ulcer assessed by tenderness to the touch by clinician (recorded as present or absent)
6 weeks
Secondary Outcomes (1)
Costs treated per ulcer
1 year
Study Arms (4)
Standard Care - Stage III Pressure Ulcers
OTHERPatients with a stage III pressure ulcer who are randomized into this arm will be given standard treatment (hydrogel, collegense, and silver alginate dressings).
Honey Treatment - Stage III Pressure Ulcers
EXPERIMENTALPatients with a stage III pressure ulcer who are randomized into this treatment arm will be given leptospermum scoparium honey dressings for treatment of their wound.
Standard Care - Stage IV Pressure Ulcers
OTHERPatients with a stage IV pressure ulcer who are randomized into this arm will be given standard treatment (hydrogel, collegense, and silver alginate dressings).
Honey Treatment - Stage IV Pressure Ulcers
EXPERIMENTALPatients with a stage IV pressure ulcer who are randomized into this treatment arm will be given leptospermum scoparium honey dressings for treatment of their wound.
Interventions
No information available- PI left- study being withdrawn.
No information available- PI left- study being withdrawn.
Eligibility Criteria
You may qualify if:
- Adult (18 years old and older)
- Newly admitted patients with a diagnosis Pressure Ulcers (Stages III and IV) or patients who develop nosocomial pressure ulcers Stage III and Stage IV
- Ability to provide written informed consent (either patient or legal personal representative)
You may not qualify if:
- Patient/representative refuses to give written informed consent
- Patient diagnosed with terminal illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYC Health + Hospitals/Coney Island
Brooklyn, New York, 11235, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2016
First Posted
February 23, 2016
Study Start
March 1, 2018
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
April 18, 2018
Record last verified: 2018-04